{"action":"elsewhere","city":"Dover","companyRegistrationNumber":null,"conformityFlag":"NON_CONFORMING","country":"US","createdAt":"1988-04-28T00:00:00.000Z","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[{"category":"DIRECT_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_CONSOLIDATING"],"references":[]},{"category":"ULTIMATE_ACCOUNTING_CONSOLIDATION_PARENT","reasons":["NON_CONSOLIDATING"],"references":[]}],"parents":[]},"headquartersAddress":"4995 Bradenton Avenue, Suite 240","headquartersCity":"Dublin","headquartersCountry":"US","headquartersPostalCode":"43017","headquartersRegion":"US-OH","lastUpdatedAt":"2026-08-27T18:20:42.420Z","legalAddress":"C/O Registered Agent Solutions, Inc., 838 Walker Road, Suite 21-2","legalFormAbbreviation":null,"legalFormCode":"XTIQ","legalFormName":"Corporation","legalJurisdiction":"US-DE","legalName":"NAVIDEA BIOPHARMACEUTICALS, INC.","lei":"549300HXUMV6VNCPEE05","managingLou":"5493001KJTIIGC8Y1R12","managingLouName":"Bloomberg","managingLouWebsite":"http://lei.bloomberg.com","nextRenewalAt":"2024-01-19T19:30:00.000Z","otherLegalForm":null,"postalCode":"19904","region":"US-DE","registeredAt":"2019-01-25T15:33:00.000Z","registrationAuthorityId":"RA000602","registrationAuthorityName":"Division of Corporations, Department of State","registrationAuthorityWebsite":"https://corp.delaware.gov/","registrationNumber":"2159135","registrationNumberFormatted":"2159135","registrationStatus":"LAPSED","served":false,"successorLeis":[],"validationAuthorityEntityId":"2159135","validationAuthorityId":"RA000602","validationAuthorityName":"Division of Corporations, Department of State","validationSources":"FULLY_CORROBORATED"}